Citerio P
Regione Lombardia, U.S.L. 58, Melzo.
Minerva Med. 1991 Sep;82(9):565-8.
We studied 19 in patients with serious pulmonary or genito-urinary infections related to cancer of various origin. The patients were treated with amikacin (7.5 mg/kg/day) and clindamycin. The clinical response was found "satisfactory" in 16 of the treated group; the bacteriological response was "good" in 12 and "nearly good" in 4 of treated patients. We found no side-effects.
我们研究了19例患有与各种起源癌症相关的严重肺部或泌尿生殖系统感染的住院患者。这些患者接受了阿米卡星（7.5毫克/千克/天）和克林霉素治疗。治疗组中有16例患者的临床反应被认为“令人满意”；12例患者的细菌学反应“良好”，4例患者的细菌学反应“近乎良好”。我们未发现副作用。
